ArticleJournal of cardiovascular electrophysiology2026
Detection of Spatio-Temporal Dispersion Electrograms Using Complex Signal Identification-Labeled Abnormal Potential Areas in Patients With Persistent Atrial Fibrillation.
Article in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAblation targeting spatio-temporal dispersion electrograms (STDEs) in addition to pulmonary vein isolation (PVI) has been reported to reduce atrial fibrillation (AF) recurrence in patients with persistent AF.
backgroundHowever, STDE identification remains subjective. Complex Signal Identification (CSI), integrated into the CARTO 3 mapping system, automatically quantifies electrogram characteristics. We evaluated whether CSI parameters can accurately identify STDEs.
methodsWe retrospectively analyzed intracardiac electrogram points from five consecutive patients who underwent catheter ablation for persistent AF using the CARTO 3 version 8 mapping system (Biosense Webster, Diamond Bar, CA, USA) between October and December 2024 to evaluate the ability of CSI parameters to identify STDEs. STDEs were identified and marked by the operator using an OCTARAY catheter.
resultsA total of 4453 electrogram points obtained before ablation were analyzed. Among all CSI metrics, the fractionation score demonstrated the highest diagnostic accuracy. An optimal cutoff of 4.1 yielded an area under the curve (AUC) of 0.905 (95% CI: 0.892-0.918), with a sensitivity of 80.4%, specificity of 98.6%, positive predictive value of 94.1%, and negative predictive value of 93.1%. In contrast, complex duration (cutoff ≥ 50 ms), %cycle length (cutoff ≥ 15%), and complex onset (cutoff ≤ -32) showed AUCs of 0.613 (95% CI: 0.557-0.668), 0.599 (95% CI: 0.538-0.660), and 0.525 (95% CI: 0.461-0.589), respectively.
conclusionA CSI fractionation score cutoff of 4.1 identified STDEs with high accuracy, suggesting that CSI-guided mapping may serve as a practical tool for adjunctive ablation beyond PVI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.